Characterization of preclinical Alzheimer's disease model: spontaneous type 2 diabetic cynomolgus monkeys with systemic pro-inflammation, positive biomarkers and developing AD-like pathology.

Background: The key to the prevention and treatment of Alzheimer's disease (AD) is to be able to predict and diagnose AD at the preclinical or early stage, but the lack of a preclinical model of AD is the critical factor that causes this problem to remain unresolved.

Methods: We assessed 18 monkeys in vivo evaluation of pro-inflammatory cytokines and AD pathological biomarkers (n = 9 / type 2 diabetic mellitus (T2DM) group, age 20, fasting plasma glucose (FPG) ≥ 100 mg/dL, and n = 9 / negative control (NC) group, age 17, FPG < 100 mg/dL). Levels of pro-inflammatory cytokines and AD pathological biomarkers was measured by ELISA and Simoa Technology, respectively.

In-situ activator-induced evolution of morphology on carbon materials for supercapacitors.

Carbonaceous materials with diverse morphologies have shown unique and excellent performance in many fields, such as catalysis, adsorption, separation and energy storage. However, regulating the structural changes of these morphologies accurately using simple approaches is a difficult process. In this study, porous carbon materials with a morphology that changed from carbon spindles to fold-carbon spheres and then to regular carbon spheres were prepared assisted by in-situ activator of KNO in co-assembly of resorcinol/phenol resin and 1-alkyl-3-methylimidazolium bromide.